Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Dise... (common symptoms of COPD are breathlessne...)

HOME >> MEDICINE >> TECHNOLOGY

Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Date:9/2/2008

common symptoms of COPD are breathlessness (or a "need for air"), abnormal sputum (a mix of saliva and mucus in the airway), and a chronic cough. Daily activities, such as walking up a short flight of stairs or carrying a suitcase, can become very difficult as the condition gradually worsens(2). There are significant unmet needs in the treatment of COPD including limited therapeutic options to improve lung function and control exacerbations.

About aclidinium bromide and Genuair(R)

Aclidinium bromide is a novel, long-acting inhaled anticholinergic bronchodilator which has a long residence time at the M3 receptors and a shorter residence time at the M2 receptors. Aclidinium is rapidly hydrolyzed in human plasma to two major inactive metabolites. Forest Laboratories licensed US rights for aclidinium from Almirall, while Almirall maintains rights for the rest of the world. The companies are jointly involved in the development of the compound.

Aclidinium bromide is administered to patients using a novel, state-of-the-art multidose dry powder inhaler (MDPI), Genuair(R). Genuair(R) was designed with an intuitive feedback system, which through a 'coloured control window', an audible click and a slightly sweet taste indicates that the patient has inhaled correctly. The Genuair(R) inhaler contains 30 doses with a visible dose level indicator and also incorporates significant safety features such as an anti-double dosing mechanism and an end-of-dose lock-out system to prevent use of an empty inhaler.

About Forest Laboratories

Forest Laboratories (NYSE: FRX) is a US-based pharmaceutical company with a long track record of building partnerships and developing and delivering products that make a positive difference in people
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients

Post Your Comments:

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ -- Chindex International, Inc. ... healthcare company providing services in China ... Healthcare, a network of private hospitals and affiliated ... its Beijing United Family Rehabilitation Hospital ("BJU Rehab ... the United Family Healthcare ("UFH") network. On June ...

(Date:6/19/2013)... Israel , June 19, 2013 ... phase I study in volunteers, and preliminary results from ... ND0612, were presented at the 2013 International Congress of ... levodopa/carbidopa liquid drug formula under development for continuous administration ... constant levodopa plasma concentrations. ND0612 has been ...

(Date:6/19/2013)... , June 19, 2013 Omnicell, Inc. ... of medication and supply management solutions and analytics ... was named the number one overall pharmacy equipment ... Infrastructure Report. KLAS, a leading independent healthcare research ... equipment vendors in its annual rankings. Omnicell also ...

Breaking Medicine Technology:Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4 Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5 NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2 NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3 NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4 NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5 NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6 Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2 Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3 Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4

[0] Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital [0] NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease [0] Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings

... reason to avoid discussing ED, a ... potential precursor to heart disease, INDIANAPOLIS, July 16 ... dysfunction (ED) surveyed,recognize it as an indicator of other health conditions, ... the condition,with their doctors. The survey, conducted by Ipsos Public Affairs ...

... Phase 2a Clinical Trial at UCSD, ... ("Raptor" or the "Company") (OTC Bulletin Board:,RPTP), ... agreement (the,"Agreement") with the University of California, ... clinical trial to evaluate a delayed-release preparation,of ...

Cached Medicine Technology:The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 2 The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 3 The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 4 The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds 5 Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2 Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3 Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4 Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5

The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease

(Date:6/19/2013)... DiscountFurnaceFilter.com, the number one solution for homeowner’s indoor ... Saver kit at an exceptional price. The 5-2-1 Compressor Saver ... conditioning unit during start up, saving wear and tear on ... burn out. , The 5-2-1 Compressor Saver works ... less power to start and drastically reduces the rush of ...

(Date:6/19/2013)... Beverly Hills, CA (PRWEB) June 19, 2013 ... Beverly Hills, permits some patients to quit using drugs ... Kern and Adi Jaffe, the founders of Alternatives, believe ... “hit Bottom” before they enter treatment and that this ... that 22 million people in the United States need ...

(Date:6/19/2013)... City, MO (PRWEB) June 19, 2013 Kansas City ... part of Main Street Day . A section of Main ... pedestrian traffic during the afternoon of the event. The Main ... host the event, which will help Kansas City join the ranks ... used Ciclovia as a tool to foster community vibrancy and active ...

(Date:6/19/2013)... Bellingham, Washington (PRWEB) June 19, 2013 ... before physicians deem it medically necessary, according to ... Maternal and Child Health Journal. The results of ... advocating for more than a decade – that ... care, and maintaining a healthy body weight. Fairhaven ...

(Date:6/19/2013)... June 19, 2013 In 2011, the ... EUR 710 million. Generic drugs form the largest sector, ... value. The pharmaceutical industry is a significant contributor to ... the country’s GDP. Approximately 50% of the total domestic ... pharmaceutical industry. Hemofarm, Galenika and Zdravlje Actavis are key ...

Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2 Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3 Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2 Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3 Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2 Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3 Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4 Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2

[0] DiscountFurnaceFilter.Com is Pleased to Offer the 5-2-1 Compressor Saver Kit at an Exceptional Price [0] Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment [0] Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia [0] Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies [0] Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com

... in March , , DETROIT, June 30 The National ... the blind in the United States, will hold its third March ... City March for Independence is a 5K walk held as part ... place in Detroit this year. Over one thousand blind Americans, ...

... an unmitigated success, welcoming 1012 visitors who left the show impressed ... June 30 A total success. That ... Summit , held for the first time on June 15-16, 2009 ... exhibition welcomed over 1000 key decision-makers in the food industry, in ...

... contribute to solving the world,s major problems over the next five ... special 25th anniversary edition of Issues in Science and Technology ... for science to deliver on its potential to enhance prosperity, security, ... respond. , , Vaclav Smil on the need ...

... medical device company Intelligent Hospital Systems (IH Systems) ... the Computerworld Honors Program Awards Gala on June ... the award in recognition of its RIVA System ... software, robotics and engineering to automate IV preparation ...

... 30 The Renal Physicians Association (RPA) supports Kidney ... in Kidney Care (PEAK) initiative. RPA is a member ... dialysis providers, physicians, manufacturers, and nurses who work together ... The goal of the PEAK campaign is to reduce ...

... found evidence that chronic disease in either a mother ... that are associated with the development of polycystic ovarian ... that brothers of women with PCOS and insulin resistance ... or diabetes, suggesting that factors associated with the condition ...

Cached Medicine News:Health News:Over One Thousand Blind Americans to March in Detroit 2 Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 2 Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 3 Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 4 Health News:Articles by Prominent Scientists Featured in 25th Anniversary Issue 2 Health News:Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society 2 Health News:Polycystic ovarian syndrome: New light on its causes and its effect on brothers 2 Health News:Polycystic ovarian syndrome: New light on its causes and its effect on brothers 3 Health News:Polycystic ovarian syndrome: New light on its causes and its effect on brothers 4

Over One Thousand Blind Americans to March in Detroit Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America Articles by Prominent Scientists Featured in 25th Anniversary Issue Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society Renal Physicians Association Participates in PEAK Campaign Polycystic ovarian syndrome: New light on its causes and its effect on brothers

Specimen mounts are designed to allow for the rotation of the specimen in the Vibratome vice assembly for sectioning at different horizontal orientations....

... provides a convenient reservoir of cooling water for the ... extended period of time or in a location which ... the hot side of the thermoelectric heat pump. ... is adequate to run the 900R for up to ...

Punch set for Advanced Tissue Arrayer, 2.0 mm...

Inquire...

Medicine Products:

Specimen Mounts 1/2" head Vibratome 900 R Closed Loop Water System Arrayer Punch Set, 2.0 mm, for ATA100, Recipient & Donor, Needles, Styli, & Collets Donor Needle, 2.0 mm, Spare part for ATA100